Literature DB >> 17464292

Suitability of hCMV for viral gene expression in the brain.

Sergey Kasparov.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17464292     DOI： 10.1038/nmeth0507-379a

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  6 in total

1.  Optical control of retrogradely infected neurons using drug-regulated "TLoop" lentiviral vectors.

Authors:  Ali Cetin; Edward M Callaway
Journal:  J Neurophysiol       Date:  2014-02-26       Impact factor: 2.714

2.  Phosphatidylserine immobilization of lentivirus for localized gene transfer.

Authors:  Seungjin Shin; Hannah M Tuinstra; David M Salvay; Lonnie D Shea
Journal:  Biomaterials       Date:  2010-03-04       Impact factor: 12.479

3.  Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.

Authors:  Ilya V Ulasov; Matthew A Tyler; Angel A Rivera; Dirk M Nettlebeck; Joanne T Douglas; Maciej S Lesniak
Journal:  J Med Virol       Date:  2008-09       Impact factor: 2.327

Review 4.  Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma.

Authors:  Oleg Mozhei; Anja G Teschemacher; Sergey Kasparov
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

5.  Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells.

Authors:  Leonardo D'Aiuto; Roberto Di Maio; Brianna Heath; Giorgio Raimondi; Jadranka Milosevic; Annie M Watson; Mikhil Bamne; W Tony Parks; Lei Yang; Bo Lin; Toshio Miki; Jocelyn Danielle Mich-Basso; Ravit Arav-Boger; Etienne Sibille; Sarven Sabunciyan; Robert Yolken; Vishwajit Nimgaonkar
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

Review 6.  Human Neural Stem Cell Systems to Explore Pathogen-Related Neurodevelopmental and Neurodegenerative Disorders.

Authors:  Matteo Baggiani; Maria Teresa Dell'Anno; Mauro Pistello; Luciano Conti; Marco Onorati
Journal:  Cells       Date:  2020-08-12       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.